GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Price-to-Free-Cash-Flow

Level Bio AB (XSAT:LEVBIO) Price-to-Free-Cash-Flow : N/A (As of Jun. 07, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Price-to-Free-Cash-Flow?

As of today (2024-06-07), Level Bio AB's share price is kr0.288. Level Bio AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.07. Hence, Level Bio AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Level Bio AB's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, Level Bio AB's highest Price-to-Free-Cash-Flow Ratio was 86.22. The lowest was 12.40. And the median was 17.68.

XSAT:LEVBIO's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.58
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Level Bio AB's Free Cash Flow per Share for the three months ended in Mar. 2024 was kr-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-0.07.

During the past 13 years, Level Bio AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 244.80% per year. The lowest was -146.60% per year. And the median was 71.65% per year.


Level Bio AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Level Bio AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Price-to-Free-Cash-Flow Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 330.00 36.29 98.85 18.93 -

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Level Bio AB's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Level Bio AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Price-to-Free-Cash-Flow falls into.



Level Bio AB Price-to-Free-Cash-Flow Calculation

Level Bio AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.288/-0.07
=N/A

Level Bio AB's Share Price of today is kr0.288.
Level Bio AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Level Bio AB  (XSAT:LEVBIO) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Level Bio AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines